Cargando…

Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA

Colorectal cancer (CRC) is the third most prevalent cancer and the second most common cause of cancer-related deaths in the United States (USA). Early screening has been demonstrated to improve clinical outcomes for CRC. Assessing patterns in CRC screening utilization is important for guiding policy...

Descripción completa

Detalles Bibliográficos
Autores principales: Ansa, Benjamin E., Lewis, Nicollette, Hoffman, Zachary, Datta, Biplab, Johnson, J. Aaron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151945/
https://www.ncbi.nlm.nih.gov/pubmed/34065816
http://dx.doi.org/10.3390/healthcare9050569
_version_ 1783698503489290240
author Ansa, Benjamin E.
Lewis, Nicollette
Hoffman, Zachary
Datta, Biplab
Johnson, J. Aaron
author_facet Ansa, Benjamin E.
Lewis, Nicollette
Hoffman, Zachary
Datta, Biplab
Johnson, J. Aaron
author_sort Ansa, Benjamin E.
collection PubMed
description Colorectal cancer (CRC) is the third most prevalent cancer and the second most common cause of cancer-related deaths in the United States (USA). Early screening has been demonstrated to improve clinical outcomes for CRC. Assessing patterns in CRC screening utilization is important for guiding policy and implementing programs for CRC prevention and control. This study examines the trends and sociodemographic factors associated with blood stool test utilization (BSTU) for CRC screening in Georgia, USA. The Behavioral Risk Factor Surveillance System (BRFSS) data were analyzed for Average Annual Percent Change (AAPC) in BSTU between 1997 and 2014 among adults aged 50+ who have had a blood stool test within the past two years, and logistic regression analysis of the 2016 data was performed to identify the associated sociodemographic factors. In Georgia, an overall decrease was observed in BSTU, from 27.8% in 1997 to 16.1% in 2014 (AAPC = −2.6, p = 0.023). The decrease in BSTU was less pronounced in Georgia than nationally (from 26.1% in 1997 to 12.8% in 2014 (AAPC = −4.5, p < 0.001)). BSTU was significantly associated with black race/ethnicity (Black vs. White (aOR = 1.43, p = 0.015)), older age (≥70 vs. 50–59 (aOR = 1.62, p = 0.006)), having insurance coverage (no vs. yes (aOR = 0.37 p = 0.005)), and lower income (≥USD 50,000 vs. <USD 25,000 (aOR = 0.70 p = 0.050)). These findings reveal a decrease over time in BSTU in Georgia, with existing differences between sociodemographic groups. Understanding these patterns helps in directing tailored programs for promoting CRC screening, especially among disadvantaged populations.
format Online
Article
Text
id pubmed-8151945
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81519452021-05-27 Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA Ansa, Benjamin E. Lewis, Nicollette Hoffman, Zachary Datta, Biplab Johnson, J. Aaron Healthcare (Basel) Article Colorectal cancer (CRC) is the third most prevalent cancer and the second most common cause of cancer-related deaths in the United States (USA). Early screening has been demonstrated to improve clinical outcomes for CRC. Assessing patterns in CRC screening utilization is important for guiding policy and implementing programs for CRC prevention and control. This study examines the trends and sociodemographic factors associated with blood stool test utilization (BSTU) for CRC screening in Georgia, USA. The Behavioral Risk Factor Surveillance System (BRFSS) data were analyzed for Average Annual Percent Change (AAPC) in BSTU between 1997 and 2014 among adults aged 50+ who have had a blood stool test within the past two years, and logistic regression analysis of the 2016 data was performed to identify the associated sociodemographic factors. In Georgia, an overall decrease was observed in BSTU, from 27.8% in 1997 to 16.1% in 2014 (AAPC = −2.6, p = 0.023). The decrease in BSTU was less pronounced in Georgia than nationally (from 26.1% in 1997 to 12.8% in 2014 (AAPC = −4.5, p < 0.001)). BSTU was significantly associated with black race/ethnicity (Black vs. White (aOR = 1.43, p = 0.015)), older age (≥70 vs. 50–59 (aOR = 1.62, p = 0.006)), having insurance coverage (no vs. yes (aOR = 0.37 p = 0.005)), and lower income (≥USD 50,000 vs. <USD 25,000 (aOR = 0.70 p = 0.050)). These findings reveal a decrease over time in BSTU in Georgia, with existing differences between sociodemographic groups. Understanding these patterns helps in directing tailored programs for promoting CRC screening, especially among disadvantaged populations. MDPI 2021-05-12 /pmc/articles/PMC8151945/ /pubmed/34065816 http://dx.doi.org/10.3390/healthcare9050569 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ansa, Benjamin E.
Lewis, Nicollette
Hoffman, Zachary
Datta, Biplab
Johnson, J. Aaron
Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA
title Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA
title_full Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA
title_fullStr Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA
title_full_unstemmed Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA
title_short Evaluation of Blood Stool Test Utilization for Colorectal Cancer Screening in Georgia, USA
title_sort evaluation of blood stool test utilization for colorectal cancer screening in georgia, usa
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8151945/
https://www.ncbi.nlm.nih.gov/pubmed/34065816
http://dx.doi.org/10.3390/healthcare9050569
work_keys_str_mv AT ansabenjamine evaluationofbloodstooltestutilizationforcolorectalcancerscreeningingeorgiausa
AT lewisnicollette evaluationofbloodstooltestutilizationforcolorectalcancerscreeningingeorgiausa
AT hoffmanzachary evaluationofbloodstooltestutilizationforcolorectalcancerscreeningingeorgiausa
AT dattabiplab evaluationofbloodstooltestutilizationforcolorectalcancerscreeningingeorgiausa
AT johnsonjaaron evaluationofbloodstooltestutilizationforcolorectalcancerscreeningingeorgiausa